| 000 | 01881 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516180553.0 | ||
| 264 | 0 | _c20150408 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1553-3840 | ||
| 024 | 7 |
_a10.1515/jcim-2013-0020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChiu, Simon | |
| 245 | 0 | 0 |
_aLiposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug platform. _h[electronic resource] |
| 260 |
_bJournal of complementary & integrative medicine _cNov 2013 |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Genetically Modified |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
| 650 | 0 | 4 |
_aExploratory Behavior _xdrug effects |
| 650 | 0 | 4 | _aGene Knockout Techniques |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHistone Deacetylases _xdrug effects |
| 650 | 0 | 4 |
_aNootropic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aPsychomotor Disorders _xdrug therapy |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aTerpstra, Kristen J | |
| 700 | 1 | _aBureau, Yves | |
| 700 | 1 | _aHou, Jirui | |
| 700 | 1 | _aRaheb, Hana | |
| 700 | 1 | _aCernvosky, Zack | |
| 700 | 1 | _aBadmeav, Vladimir | |
| 700 | 1 | _aCopen, John | |
| 700 | 1 | _aHusni, Mariwan | |
| 700 | 1 | _aWoodbury-Farina, Michael | |
| 773 | 0 |
_tJournal of complementary & integrative medicine _gvol. 10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/jcim-2013-0020 _zAvailable from publisher's website |
| 999 |
_c23239557 _d23239557 |
||